secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q32 Bio Inc. (QTTB)
CIK:        0001661998
Form:       8-K
Filed at:   2026-02-17T23:59:59+00:00
Accession:  0001193125-26-054711
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Q32 Bio raises $10.5M in registered direct offering to fund bempikibart trials
------------------------------------------------------------------------------

- Gross proceeds of ~$10.5M from 1,666,679 common shares and pre-funded warrants for 1,025,654 shares at $3.90/share.
- Offering price equals Feb 13 closing price; pre-funded warrants exercisable at $0.0001/share.
- Net proceeds for working capital, including advancing bempikibart for alopecia areata into future trials.
- Closing expected Feb 18, 2026; led by new institutional investor with participation from existing investor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661998/000119312526054711/0001193125-26-054711-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661998/000119312526054711/d113308d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-054711

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer